SERRATRIN®

Your lifetime of mobility starts today

OVERVIEW

Serratrin is a novel, full-spectrum Boswellia serrata extract, standardized to ≥ 30% boswellic acids. It is derived from two different extracts of Boswellia and formulated for maximum benefits. Boswellia has been used in the Ayurvedic medicine tradition for thousands of years. Serratrin takes this tradition and scientifically improves it for modern day use.

Serratrin Improves Knee Function

80-Meter Fast-Paced Walk Test
Serratrin showed significant improvement in the 80-meter fast-paced walk test as early as 7 days over placebo.

30-Second Chair Test

Serratrin showed significant improvement in the 30-second chair stand test as early as 7 days compared with placebo.

Serratrin Improves Knee Joint Comfort

VAS Score
Serratrin significantly improved Mean VAS score as early as 7 days.

WOMAC Scores

Serratrin significantly improved Average WOMAC scores as early as 7 days compared to placebo.

A Sustainable and Socially Responsible Ingredient

Serratrin is made from the gum resin of the Indian frankincense (Boswellia serrata) tree. Boswellia gum resin is also ttraditionally known as Indian olibanum, Salai guggul, and Sallaki in Sanskrit. The plant is native to much of India and the Punjab region that extends into Pakistan.

PLT Boswellia serrata materials are sourced in India from the states of Andhra Pradesh and Madhya Pradesh. The entire Boswellia serrata supply chain starts with deep, long-term relationships developed with the most trustworthy collectors and aggregators that have been decades in the making. In conjunction with the Indian forestry department, collectors are trained on sustainable gum tapping methods to maximize yield while maintaining the safety and health of the Boswellia serrata tree populations. Tapping locations on the tree bark, as well as the frequency of tapping, are carefully controlled to maintain good tree health.

In early 2022, PLT Health Solutions announced the commencement of a third-party sustainability audit program on Boswellia serrata trees in India by renowned botanical research consultancy Botanical Liaisons, LLC. The third-party audit program is based on a broad range of environmental, cultural and economic parameters

At PLT, we understand that proper stewardship of natural resources and social responsibility toward the communities that support our work is both the right thing to do and good business.

Developed at Laila Impex Research Center

Serratrin was developed by Laila Nutraceuticals, a division of Laila Group, India’s leading producer of herbal extracts. The Research Center is accredited by the Government of India, Department of Scientific and Industrial Research (DSIR) and has partnered with various universities in its PhD research projects. The Laila Impex Research Center also has partnerships with Georgetown University in Washington, D.C., Ohio State University Medical Center, University of Kansas Medical Center, University of California, Davis, and Vienna Medical College in Austria.

Our international network, passionate team of experts and extensive industry knowledge is what sets us apart.